中金辐照 reported revenue of ¥0.18B for the period ended 2026-06-30, +1.0% year on year. Net income was ¥0.04B, a 23.5% net margin on a 57.9% gross margin. The largest revenue line is 辐照技术服务 at 93% of the total. Free cash flow for the period was ¥-0.06B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.18B | +1.0% |
| Gross profit | ¥0.11B | — |
| Operating income | ¥0.05B | — |
| Net income | ¥0.04B | -36.7% |
| Gross margin | 57.9% | Net margin 23.5% |
| Revenue Q/Q | +10.4% | — |
| Segment | Revenue | Share |
|---|---|---|
| 辐照技术服务 | ¥0.17B | 93.4% |
| 其他主营业务 | ¥0.01B | 5.3% |
| 其他(补充) | ¥0.00B | 1.2% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.08B | 42.1% |
| R&D | ¥0.01B | 6.9% |
| SG&A | ¥0.03B | 17.5% |
| Tax & other | ¥0.01B | 5.3% |
| Item | Amount |
|---|---|
| Total assets | ¥1.67B |
| Total liabilities | ¥0.57B |
| Shareholders' equity | ¥1.10B |
| Equity / assets | 65.7% |
| Operating cash flow | ¥0.02B |
| Capital expenditure | ¥0.09B |
| Free cash flow | ¥-0.06B |
| Cash conversion (OCF / net income) | 109% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
中洲特材 ・ 本川智能 ・ 恒宇信通 ・ 共同药业 ・ 晓鸣股份 ・ 格林精密 ・ 恒帅股份 ・ 华绿生物 ・ 博亚精工 ・ 万辰集团 ・ 立高食品 ・ 商络电子
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies